Enzalutamide-induced hypoxia attenuates response and promotes resistance to enzalutamide in preclinical models of prostate cancer.-MedSci.cn

Enzalutamide-induced hypoxia attenuates response and promotes resistance to enzalutamide in preclinical models of prostate cancer.

Maxwell, PJ; McKechnie, M; Duddy, O; Armstrong, CW; Manley, JM; Ong, CW; Worthington, J; Deryugina, E; Quigley, JP; Zoubeidi, A; Waugh, DJJ; LaBonte, MJ

CANCER RESEARCH, 2018; 78 (16): 72

科室
- - 订阅+
  - 更多科室
工具
服务